Industrial Alliance Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,408
Closed -$324K 9
2023
Q2
$324K Sell
2,408
-139,175
-98% -$20.4M 0.17% 53
2023
Q1
$22.6M Buy
141,583
+11,090
+8% +$1.7M 0.63% 35
2022
Q4
$21.1M Buy
130,493
+1,739
+1% +$267K 0.59% 40
2022
Q3
$17.3M Sell
128,754
-60,862
-32% -$8.73M 0.51% 49
2022
Q2
$29M Buy
189,616
+50,298
+36% +$7.69M 0.83% 26
2022
Q1
$22.6M Sell
139,318
-35,884
-20% -$5.21M 0.53% 44
2021
Q4
$23.7M Buy
+175,202
New +$20.7M 0.55% 40

Other funds holding ABBV

Industrial Alliance Investment Management's ABBV Position: Q3 2023 in Review

Industrial Alliance Investment Management sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 2,408 shares — an estimated $324K sold.

Industrial Alliance Investment Management first reported a position in ABBV in Q4 2021 and held it in 7 quarters. The position peaked at $29M in Q2 2022. 3,110 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Industrial Alliance Investment Management reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
  • Industrial Alliance Investment Management sold 2,408 AbbVie shares in Q3 2023, an estimated $324K.
  • Industrial Alliance Investment Management first reported a position in AbbVie in Q4 2021 and held it in 7 quarters.
  • Industrial Alliance Investment Management's AbbVie position peaked at $29M in Q2 2022.
  • 3,110 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Industrial Alliance Investment Management's 13F filing for Q3 2023, filed 15 Nov 2023.